ELI LILLY & Co
LLYAPI behind this page
LLY Q4 2025 request
Playground key active
/api/financials?ticker=LLY&year=2025&quarter=4
Pick an endpoint and run the request.Income Statement
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Cardiometabolic Health · Non Us | 4,435.5 | 2,579.4 | +72.0% |
| Cardiometabolic Health · US | 10,056.7 | 6,527 | +54.1% |
| Collaboration and Other Revenue [Member] | 991.7 | 1,508.1 | -34.2% |
| Immunology · Non Us | 629.4 | 524 | +20.1% |
| Immunology · US | 911.6 | 767 | +18.9% |
| Jardiance | 768.6 | 1,198.5 | -35.9% |
| Jardiance · Non Us | 301.8 | 733.6 | -58.9% |
| Jardiance · US | 465.8 | 464.9 | +0.2% |
| Mounjaro · Non Us | 3,267 | 898.7 | +263.5% |
| Mounjaro · US | 4,143.2 | 2,631.3 | +57.5% |
| Neuroscience · Non Us | 139 | 170 | -18.2% |
| Neuroscience · US | 320.2 | 223.6 | +43.2% |
| Oncology · Non Us | 1,095.4 | 1,084.4 | +1.0% |
| Oncology · US | 1,511.9 | 1,468.1 | +3.0% |
| Other cardiometabolic health · Non Us | 492.4 | 496.4 | -0.8% |
| Other cardiometabolic health · US | 524.5 | 723.2 | -27.5% |
| Other immunology · Non Us | 301.6 | 237.7 | +26.9% |
| Other immunology · US | 187.3 | 101.7 | +84.2% |
| Other oncology · Non Us | 487.8 | 571.5 | -14.6% |
| Other oncology · US | 514.9 | 425.5 | +21.0% |
| Other · Non Us | 114.4 | 144.6 | -20.9% |
| Other · US | 77 | 46 | +67.4% |
| Product | 18,300.3 | 12,025 | +52.2% |
| Taltz · Non Us | 327.8 | 286.3 | +14.5% |
| Taltz · US | 724.3 | 665.3 | +8.9% |
| Trulicity · Non Us | 344 | 450.7 | -23.7% |
| Trulicity · US | 692.8 | 800 | -13.4% |
| Verzenio · Non Us | 607.6 | 512.9 | +18.5% |
| Verzenio · US | 997 | 1,042.6 | -4.4% |
| Zepbound · US | 4,230.4 | 1,907.6 | +121.8% |
Show Business Segments breakouts |
|||
| Reportable Segment | 19,292 | 13,533.1 | +42.6% |
Show Geography breakouts |
|||
| CN | 473.2 | 428.8 | +10.4% |
| Europe | 3,096.8 | 2,448.3 | +26.5% |
| JP | 654.8 | 559.3 | +17.1% |
| Non Us | 6,414.6 | 4,501.3 | +42.5% |
| Rest of world | 2,189.8 | 1,063.9 | +105.8% |
| US | 12,877.4 | 9,031.8 | +42.6% |
Show — breakouts |
|||
| Revenue | 19,292 | 13,533.1 | +42.6% |
| Revenue | -33,358.9 | -20,114.6 | -65.8% |
| Cost of Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 3,371.7 | 2,403.5 | +40.3% |
Show — breakouts |
|||
| Cost of Revenue | 3,371.7 | 2,403.5 | +40.3% |
| Research And Development Expense Excluding Acquired In Process Cost (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Early-stage · Reportable Segment | 1,485.4 | 1,044.4 | +42.2% |
| Late-stage · Reportable Segment | 2,316.1 | 1,978.5 | +17.1% |
Show — breakouts |
|||
| Research And Development Expense Excluding Acquired In Process Cost | 3,801.5 | 3,022.9 | +25.8% |
| Selling, General & Administrative (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 3,131.4 | 2,424.7 | +29.1% |
Show — breakouts |
|||
| Selling, General & Administrative | 3,131.4 | 2,424.7 | +29.1% |
| Research And Development Asset Acquired Other Than Through Business Combination Written Off (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 528.8 | 188.8 | +180.1% |
Show — breakouts |
|||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | 528.8 | 188.8 | +180.1% |
| Restructuring Settlement And Impairment Provisions (Q) | — | — | — |
Show — breakouts |
|||
| Restructuring Settlement And Impairment Provisions | 84.1 | 344.4 | -75.6% |
| Non-Operating Income (Expense) (Q) | — | — | — |
Show — breakouts |
|||
| Non-Operating Income (Expense) | 108.3 | 110.5 | -2.0% |
| Cost Of Sales Operating Expenses And Other Net (Q) | — | — | — |
Show — breakouts |
|||
| Cost Of Sales Operating Expenses And Other Net | 11,025.8 | 8,494.8 | +29.8% |
| Income Before Taxes (Q) | — | — | — |
Show — breakouts |
|||
| Income Before Taxes | 8,266.2 | 5,038.3 | +64.1% |
| Income Tax Expense (Benefit) (Q) | — | — | — |
Show — breakouts |
|||
| Income Tax Expense (Benefit) | 1,628.5 | 628.5 | +159.1% |
| Net Income (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 6,637.7 | 4,409.8 | +50.5% |
Show — breakouts |
|||
| Net Income | 6,637.7 | 4,409.8 | +50.5% |
| EPS (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Basic) | 7.4 | 4.9 | +51.0% |
| EPS (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Diluted) | 7.39 | 4.88 | +51.4% |
| Wtd Avg Shares (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Basic) | -0.5 | -0.3 | -66.7% |
| Wtd Avg Shares (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Diluted) | -0.4 | -0.3 | -33.3% |
| Interest Expense (Q) | — | — | — |
Show — breakouts |
|||
| Interest Expense | 222.6 | 225.1 | -1.1% |
| Net Income (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Retained Earnings | 6,637.7 | 4,409.8 | +50.5% |
| Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income | 6,964.1 | 4,362.6 | +59.6% |
| Other Comprehensive Income (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 326.4 | -47.2 | +791.5% |
Show — breakouts |
|||
| Other Comprehensive Income | 326.4 | -47.2 | +791.5% |
Balance Sheet
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash & Cash Equivalents | 7,268 | 3,268 | +122.4% |
| Accounts Receivable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Receivable | 17,760 | 11,006 | +61.4% |
| Other Receivables Net Current (Q) | — | — | — |
Show — breakouts |
|||
| Other Receivables Net Current | 2,395 | 2,270 | +5.5% |
| Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Inventory | 13,744 | 7,589 | +81.1% |
| Prepaid Expense Current (Q) | — | — | — |
Show — breakouts |
|||
| Prepaid Expense Current | 14,315 | 8,341 | +71.6% |
| Other Assets Current (Q) | — | — | — |
Show — breakouts |
|||
| Other Assets Current | 147 | 266 | -44.7% |
| Total Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Assets | 55,629 | 32,740 | +69.9% |
| Non-Current Assets | |||
| Long Term Investments (Q) | — | — | — |
Show — breakouts |
|||
| Long Term Investments | 2,802 | 3,216 | -12.9% |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 2,802 | 3,216 | -12.9% |
| Goodwill (Q) | — | — | — |
Show — breakouts |
|||
| Goodwill | 5,898 | 5,770 | +2.2% |
| Intangible Assets Net Excluding Goodwill (Q) | — | — | — |
Show — breakouts |
|||
| Intangible Assets Net Excluding Goodwill | 6,521 | 6,166 | +5.8% |
| Deferred Tax Assets (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Assets | 9,959 | 8,001 | +24.5% |
| Property, Plant & Equipment (Q) | — | — | — |
Show — breakouts |
|||
| Property, Plant & Equipment | 24,675 | 17,102 | +44.3% |
| Other Non-Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Assets | 6,992 | 5,720 | +22.2% |
| Total Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Assets | 112,476 | 78,715 | +42.9% |
| Operating Lease Right-of-Use Assets (Q) | — | — | — |
Show — breakouts |
|||
| Operating Lease Right-of-Use Assets | 1,260 | 1,050 | +20.0% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Developed Technology Rights | 4,952 | 5,269 | -6.0% |
| Current Liabilities | |||
| Debt Current (Q) | — | — | — |
Show — breakouts |
|||
| Debt Current | 1,635 | 5,117 | -68.0% |
| Accounts Payable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Payable | 5,379 | 3,229 | +66.6% |
| Employee Related Liabilities Current (Q) | — | — | — |
Show — breakouts |
|||
| Employee Related Liabilities Current | 2,375 | 2,094 | +13.4% |
| Sales Rebates And Discounts (Q) | — | — | — |
Show — breakouts |
|||
| Sales Rebates And Discounts | 17,382 | 11,539 | +50.6% |
| Other Liabilities Current (Q) | — | — | — |
Show — breakouts |
|||
| Other Liabilities Current | 8,457 | 6,397 | +32.2% |
| Total Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Liabilities | 35,228 | 28,376 | +24.1% |
| Non-Current Liabilities | |||
| Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Long-Term Debt | 40,868 | 28,527 | +43.3% |
| Accrued Income Taxes Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Accrued Income Taxes Noncurrent | 5,875 | 4,061 | +44.7% |
| Other Non-Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Liabilities | 3,970 | 3,479 | +14.1% |
| Liabilities Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Liabilities Noncurrent | 50,713 | 36,067 | +40.6% |
| Long-Term Debt (Q) | — | — | — |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure | 42,503 | 29,307 | +45.0% |
| Fair Value Inputs Level2 · Estimate Of Fair Value Fair Value Disclosure | 39,799 | 26,249 | +51.6% |
Show Debt Instrument breakouts |
|||
| August 2024 Issuance Date Debt | 5,000 | — | — |
| August 2025 Issuance Date Debt | 6,750 | — | — |
| February 2023 Issuance Date Debt | 4,000 | — | — |
| February 2024 Issuance Date Debt | 6,500 | — | — |
| February 2025 Issuance Date Debt | 6,500 | — | — |
Show Long-Term Debt Type breakouts |
|||
| Floating-Rate Notes | 750 | — | — |
| Operating Lease Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Operating Lease Liabilities | 1,140 | 971 | +17.4% |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock | 590 | 592 | -0.3% |
| Additional Paid In Capital Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Additional Paid In Capital Common Stock | 7,346 | 7,439 | -1.3% |
| Retained Earnings (Q) | — | — | — |
Show — breakouts |
|||
| Retained Earnings | 24,470 | 13,545 | +80.7% |
| Common Stock Shares Held In Employee Trust (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock Shares Held In Employee Trust | -3,013 | -3,013 | 0.0% |
| Accumulated Other Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Accumulated Other Comprehensive Income | -2,880 | -4,322 | +33.4% |
| Other Additional Capital (Q) | — | — | — |
Show — breakouts |
|||
| Other Additional Capital | 22 | 31 | -29.0% |
| Total Stockholders' Equity (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -1,987 | -2,179 | +8.8% |
| Accumulated Other Comprehensive Income | -2,880 | -4,322 | +33.4% |
| Accumulated Translation Adjustment | -1,149 | -2,390 | +51.9% |
| Additional Paid In Capital | 7,346 | 7,439 | -1.3% |
| Common Stock | 590 | 592 | -0.3% |
| Other | 255 | 246 | +3.7% |
| Retained Earnings | 24,470 | 13,545 | +80.7% |
| Trust For Benefit Of Employees | -3,013 | -3,013 | 0.0% |
Show — breakouts |
|||
| Total Stockholders' Equity | 26,535 | 14,272 | +85.9% |
| Total Liabilities & Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities & Equity | 112,476 | 78,715 | +42.9% |
Cash Flow Statement
| Metric | YTD Q4 2025 | YTD Q4 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization (Q) | — | — | — |
Show — breakouts |
|||
| Depreciation & Amortization | 585.7 | 485.2 | +20.7% |
| Increase Decrease In Deferred Income Taxes (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Deferred Income Taxes | -748.1 | -966.6 | +22.6% |
| Stock-Based Compensation (Q) | — | — | — |
Show — breakouts |
|||
| Stock-Based Compensation | 136.1 | 142.3 | -4.4% |
| Other Operating Activities Cash Flow Statement (Q) | — | — | — |
Show — breakouts |
|||
| Other Operating Activities Cash Flow Statement | -61.5 | 662.3 | -109.3% |
| Net Cash from Operations (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Operations | 3,224.6 | 2,473.9 | +30.3% |
| Investing Activities | |||
| Payments To Acquire Other Property Plant And Equipment (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Other Property Plant And Equipment | -2,546.7 | -1,496.2 | -70.2% |
| Proceeds From Sale And Maturity Of Other Investments (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Sale And Maturity Of Other Investments | 132 | 56 | +135.7% |
| Payments To Acquire Other Investments (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Other Investments | -127 | -151.9 | +16.4% |
| Payments To Acquire In Process Research And Development (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire In Process Research And Development | -423.7 | -251.4 | -68.5% |
| Other Payments To Acquire Businesses (Q) | — | — | — |
Show — breakouts |
|||
| Other Payments To Acquire Businesses | -111.6 | -0.3 | -37100.0% |
| Other Investing Activities (Q) | — | — | — |
Show — breakouts |
|||
| Other Investing Activities | 56.8 | -678.2 | +108.4% |
| Net Cash from Investing (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Investing | -2,802.2 | -1,921 | -45.9% |
| Financing Activities | |||
| Payments Of Dividends (Q) | — | — | — |
Show — breakouts |
|||
| Payments Of Dividends | -1,345.5 | -1,167.9 | -15.2% |
| Proceeds From Repayments Of Short Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Repayments Of Short Term Debt | -0.4 | 3,042.1 | -100.0% |
| Proceeds From Issuance Of Long Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Issuance Of Long Term Debt | -0.2 | -0.1 | -100.0% |
| Repayments Of Long Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Repayments Of Long Term Debt | 0.1 | 0.2 | -50.0% |
| Share Repurchases (Q) | — | — | — |
Show — breakouts |
|||
| Share Repurchases | -1,507.7 | -2,053.9 | +26.6% |
| Proceeds From Payments For Other Financing Activities (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Payments For Other Financing Activities | -25.1 | -45.9 | +45.3% |
| Net Cash from Financing (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Financing | -2,878.8 | -225.5 | -1176.6% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -67.1 | -428.8 | +84.4% |
| Net Change in Cash (Q) | — | — | — |
Show — breakouts |
|||
| Net Change in Cash | -2,523.5 | -101.4 | -2388.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations (Q) | — | — | — |
Show — breakouts |
|||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 7,268 | 3,268 | +122.4% |
Values in millions USD. Source: SEC EDGAR 10-K filing.